Oxford Asset Management’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | $130K | Sell |
1,818
-11,055
| -86% | -$791K | 0.02% | 131 |
|
|
2019
Q4 | $888K | Buy |
12,873
+3,077
| +31% | +$212K | 0.02% | 931 |
|
|
2019
Q3 | $786K | Buy |
+9,796
| New | +$786K | 0.02% | 1063 |
|
|
2019
Q2 | – | Sell |
-522
| Closed | -$72K | – | 1861 |
|
|
2019
Q1 | $72K | Buy |
+522
| New | +$72K | ﹤0.01% | 1581 |
|
|
2018
Q3 | – | Sell |
-2,597
| Closed | -$455K | – | 1837 |
|
|
2018
Q2 | $455K | Sell |
2,597
-492
| -16% | -$86.2K | 0.01% | 1372 |
|
|
2018
Q1 | $453K | Buy |
3,089
+1,205
| +64% | +$177K | 0.01% | 1279 |
|
|
2017
Q4 | $387K | Buy |
+1,884
| New | +$387K | 0.01% | 1267 |
|
|
2017
Q2 | – | Sell |
-1,151
| Closed | -$259K | – | 1601 |
|
|
2017
Q1 | $259K | Sell |
1,151
-945
| -45% | -$213K | 0.01% | 1241 |
|
|
2016
Q4 | $415K | Buy |
+2,096
| New | +$415K | 0.01% | 614 |
|
|
2016
Q3 | – | Sell |
-1,749
| Closed | -$1.02M | – | 814 |
|
|
2016
Q2 | $1.02M | Buy |
+1,749
| New | +$1.02M | 0.03% | 483 |
|
|
2015
Q4 | – | Sell |
-6,090
| Closed | -$3.61M | – | 915 |
|
|
2015
Q3 | $3.61M | Hold |
6,090
| – | – | 0.11% | 187 |
|
|
2015
Q2 | $5.06M | Buy |
+6,090
| New | +$5.06M | 0.14% | 172 |
|